Colonic crypt cell proliferation is used as an indicator of risk of colorectal carcinoma. Subjects with adenomatous polyps and cancer have an increased cell proliferation and a shift of the proliferative zone towards the apex of the crypt. Epidemiological and in vitro studies have confirmed a link between vitamins A, E, C, 13-carotene, and colorectal cancer. In vitro bromodeoxyuridine immunohistochemical technique was used to assess the effect of daily oral supplementation with vitamin E (160 mg), vitamin C (750 mg), or 13-carotene (9 mg) on the colonic crypt cell proliferation in patients with adenomatous polyps (n=40) compared with normal subjects with no colonic disease (n=20). The patients were given supplementation for one month and colonic biopsy specimens were taken before and at the end of the trial. Patients with adenomatous polyps had a significantly higher mean labelling index per cent than controls (p<0-001). Vitamic C or 13-carotene supplementation, however, significantly reduced the total proliferation (p<0.005) whereas vitamin E supplementation had no effect on the colonic crypt cell proliferation. 13-carotene reduced cell proliferation at the base of the crypt only. Vitamin C reduced cell proliferation in all the crypt compartments from the apex to the base to those values seen in age and sex matched controls. These findings indicate that prolonged supplementation with vitamin C may reduce the recurrence of adenomatous polyps.
The aim of this study was to assess the effect of oral supplementation with vitamin C, vitamin E, or 1-carotene on colonic crypt cell proliferation of patients with adenomatous polyps.
Patients and methods Sixty nine subjects undergoing colonoscopy were recruited for this study. These were aged between 34-80, had a complete colonoscopic examination of the large bowel, were capable of following the study protocol, and gave a written informed consent.
Subjects were excluded from the study if they suffered from any debilitating or life threatening disease, including invasive cancer. Patients with familial polyposis coli, inflammatory bowel disease, malabsorption syndrome, or a personal history of colonic resection were excluded. Subjects with an incomplete examination of the large bowel, severe dysplasia, or carcinoma in situ were excluded. Any subjects taking vitamin supplements within a year of entering the trial were not included in this study.
Forty subjects with adenomatous polyps proved histologically of diameter greater than 5 mm were included in the final analysis. Twenty subjects with normal colonoscopy and histologically normal colonic mucosa were included as a control group. Table I shows the demographic profile of these subjects. The patients with adenomatous polyps were assigned to one of four study groups using the random sampling quota technique allowing for 10 subjects in each study group. Group 1: no supplementation. Group 2: 160 mg of vitamin E daily. Group 3: 750 mg ofvitamin C daily. Group 4: 9 mg of 13-carotene daily. The supplementation dose was given for one month, in two or three tablets with meals. Vitamin supplements were kindly donated by Natures Own, West Malvern, United Kingdom. Colonic biopsy specimens were taken before and at the end of the supplementation period. The colonoscopies were carried out between 1100 and 1300 to allow for diurnal variation in proliferation rates.'3 Four pinch biopsy specimens were taken for cell proliferation analysis from macroscopically normal mucosa in the compartment. The samples were analysed blind by a single observer. On analysis of the total labelling index per cent (Figs 1 and 2 ) patients with adenomatous polyps had significantly higher mean (SEM) LI% (6-2 (0 3)) compared with normal controls (3 2 (O 3) ), p<0001. When the LI% was analysed before and after the trial (Table II) it was found that the total LI% or compartmental LI% did not change over the one month period in the absence of supplementation (Figs 1 and 3) .
,B-carotene supplementation significantly reduced the total LI% (p<0005) (Figs 1 and 3) . On compartmental analysis (Table II) the proliferation at the base of the crypt (compartments 3, 4, and 5) was significantly reduced, however, there was no significant reduction at the apex of the crypt (compartments 1 and 2). When the total LI% was compared with that of age and sex matched controls (Table III) , it was found that although ,6-carotene reduced the total LI% it did not reduce it to control values (Fig 4) .
Vitamin C supplementation significantly reduced the total LI% (p<0005) (Figs 1 and 3) . On compartmental analysis, proliferation in all compartments was significantly reduced (Table  II) . When these were compared with age and sex matched controls (Table III) , no significant difference was seen in any of the labelling indices (Fig 5) .
Vitamin E supplementation had no effect on the increased proliferation found in patients with adenomatous polyps.
Discussion
This study assessed the effect of antioxidant vitamin supplementation on colonic crypt cell proliferation'6 in patients with adenomatous polyps of the colon. In contrast with other vitamin supplementation studies,9'2 this study assessed the effect of single vitamin supplements only, the study was prospective with a control group, subjects with familial polyposis coli were excluded and subjects were sequentially assigned to each group. Subjects with adenomatous polyps had an increased cell proliferation with an increasing trend of proliferating cells towards the apex of the crypt as has been found by others.'ll'7 We found that vitamin E supplementation had no effect on this abnormal proliferation. 13-carotene and vitamin C supplementation significantly reduced the total cell proliferation. 5-carotene did not change the shift of the proliferative zone towards the apex of the crypt and the indices of proliferation taken after supplementation were not reduced to those found in age and sex matched controls. Vitamin C reduced the cell proliferation to that found in age and sex matched controls, it also reduced the upward shift in the proliferative zone.
Although the mean LI% of subjects with adenomatous polyps was significantly higher than those with no colonic disease (p<0-001), there was an overlap in the total LI% of both groups (Fig 2) . It is possible that the younger control subjects with a high LI% may develop an adenomatous polyp as an ageing phenomenon. found that subjects with adenomatous polyps had a significantly higher labelling index than those with no colonic disease.
The increased proliferation and the significant upwards trend of the proliferating cells towards the apex of the crypt, seen in patients with adenomatous polyps, is a product ofthe increased S-phase duration of the pre-malignant cells and may be specifically related to cancer. 16 A large prospective study by Wald et a120 found that serum vitamin E values in subjects who subsequently developed colorectal cancer were no different to those of age and sex matched controls. In vitro work has also shown that vitamin E has no effect on the regression of induced tumours, which would validate our findings in this study.
Few studies have been carried out assessing the effect of vitamin supplementation on adenomatous polyps or colorectal cancer. De Cosse et all found vitamin C and vitamin E supplementation had no effect on polyp recurrence, but in that study the supplements were taken in combination with fibre supplementation. Bussey et al9 examined the effect of vitamin C supple-mentation on cell proliferation using the tritiated thymidine technique. They found that supplementation reduced the total cell proliferation although in contrast with our results, vitamin C did not change the upward shift of the proliferative zone.
In conclusion this study has shown that both 1-carotene and vitamin C supplementation reduce the abnormal colonic crypt cell proliferation found in subjects with adenomatous polyps. Short term supplementation with vitamin C reduces the cell proliferation to normal values possibly by reducing the S-phase duration. This may reduce the risk of progression to carcinoma and the recurrence ofadenomatous polyps. Long term studies will be needed to assess if this effect is maintained. 
